최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기韓國營養學會誌 = The Korean journal of nutrition., v.41 no.7, 2008년, pp.612 - 620
윤미은 (삼육대학교 식품영양학과) , 이다홍 (원광대학교 식품영양학과) , 김미현 (강원대학교 식품영양학과)
This study assessed the effects of soy isoflavones supplementation with exercise on urinary mineral (calcium, magnesium, copper, zinc) excretion as an index of bone resorption rates in 67 postmenopausal women. A total subjects were assigned to Isoflavone (90 mg/day) or placebo groups. These groups w...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
여성에게 골다공증 발병률이 급격히 증가하는 시기는? | 삶의 질을 유지하는데 크게 영향을 미치는 질환 중의 하나인 골다공증은 폐경 이후에 여성 호르몬이 감소되면서 발병률이 급격히 증가하는 것으로 보고되었다.1-3) 우리나라의 경우에도 폐경 후 여성의 골밀도 상태가 매우 저조한 것으로 보고되었으며,4-6) 더구나 인구 통계적으로 볼 때, 폐경여성의 분포는 1960년 12. | |
여성호르몬 에스트로겐이 폐경기 골다공증의 치료에 사용된 이유는? | 폐경기 골다공증의 예방과 치료에 제안되고 있는 여성호르몬 에스트로겐은 직접적으로 조골세포의 활성을 조절하거나,8-10) 사이토카인이나 성장인자 등을 통해 간접적으로 파골세포의 생성을 조절해 골교체를 감소시켜 골용해를 저해하는11-14) 것으로 보고되어 폐경기 골다공증의 치료에 사용되어왔다. 그러나 장기간 치료 시 유방암, 자궁암 등의 여러 가지 부작용을 초래할 수 있는 것으로 보고되고 있다. | |
여성호르몬 에스트로겐을 활용한 골다공증 치료의 부작용은? | 폐경기 골다공증의 예방과 치료에 제안되고 있는 여성호르몬 에스트로겐은 직접적으로 조골세포의 활성을 조절하거나,8-10) 사이토카인이나 성장인자 등을 통해 간접적으로 파골세포의 생성을 조절해 골교체를 감소시켜 골용해를 저해하는11-14) 것으로 보고되어 폐경기 골다공증의 치료에 사용되어왔다. 그러나 장기간 치료 시 유방암, 자궁암 등의 여러 가지 부작용을 초래할 수 있는 것으로 보고되고 있다.15-18) 이에 대체로 제안되고 있는 대두 이소플라본 (Isoflavones) 은 에스트로겐과 구조가 유사하여 약하게 에스트로겐 기능을 하여 폐경 후 여성의 골격 건강에 긍정적인 영향을 주는 것으로 보고되어 왔다. |
Garnero P. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk presiction and therapy monitoring. Mol Diagn Ther 2008; 12(3): 157-170
Namiduru ES, Binnur Erbaqci A, Celik A, Yilmaz M, Tarakcioqlu M. Serum prolidase activity in postmenopausal osteoporosis. Minerva Med 2007; 98(6): 647-651
Gambacciani M, Cappaqli B, Cliapon M, Pepe A, Vacca F, Genazzani AR. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women. Maturitas 2008; 59 (1): 2-6
Choi MJ, Jung YJ. The Effects of Isoflavones Intake Level on Bone Markers and Bone Related Hormones in Growing Female Rats. Korean J Nutr 2008; 41(3): 199-205
Kim MH, Lee DH. A Comparative Study of Bone Mineral Density and Urinary Bone Metabolic Markers according to the Nutrients Intake Levels in Postmenopausal Women. Korean J Nutr 2007; 40(8): 719-727
Choi YH, Sung CJ. Effects of physiological Factors and Lifestyles on Bone Mineral Density in Postmenopausal Women. Korean J Nutr 2007; 40(6): 517-524
Park HM, Seo YS, Hur M. The distribution and transition of postmenopausal population in Korea. J Korean Menopause 1998; 4(1): 61-71
Ogita M, Rached MT, Dworakowski E, Bilezikian JP, Kousteni S. Differentiation and proliferation of periosteal Osteoblast Progenitors are Differentially Regulated by Estrogens and Intermittent PTH Administration. Endocrinology 2008; [Epub ahead of prints]
Hawse JR, Subramaniam M, Monroe DG, Hemmingsen AH, Ingle JN, Khosla S, Oursler MJ, Spelsberg TC. Estrogen Receptor{beta} Isoform-specific Induction of Transforming Growth Factor{beta}-Inducible Early Gene-1 in Human osteoblast cells. Mol Endocrinol 2008; 22(7): 1579-1595
Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL. Evidence of estrogen receptors in human osteoblast-like cells. Science 1988; 241(4861): 84-86
Gallagher JC. Advances in bone biology and new treatments for bone loss. Maturitas 2008; 60(1): 65-69
Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 1999; 13(6): 819-828
Rickard DJ, Subramaniam M, Spelsberg TC. Molecular and cellular mechanisms of estrogen action on the skeleton. J Cell Biochem 1999; 32/33(Suppl): 123-132
Robinson JA, Waters KM, Turner RT, Spelsberg TC. Direct action of anturally occurring estrogen metabolites on human osteoblastic cells. J Bone Miner Res 2000; 15(3): 499-506
Kim NN, Stankovic M, Armagan A, Cushman TT, Goldstein I, Traish AM. Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat. BMC Womens Health 2006; 6: 14
North American Menopause Society. Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society. Menopause 2003; 10(2): 113-132
Nechushton H, Peretz T, Harefuah. Tamoxifen and Breast Cancer 2002; 141(8): 718-720
Going S, Lohman T, Houtkooper L, Metcafe L, Flint-Wagner H, Blew R, Stanford V, Cussler E, Martin J, Teixeira P, Harris M, Milleken L, Figueroa-Galvez A, Weber J. Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy. Osteoporosis Int 2003; 14(8): 637-643
Shiquemoto GE, Rossi EA, Baldissera V, Gouveia CH, de Valdez Vargas GM, de Andrade Perez SE. Isoflavones-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats. Maturitas 2007; 57 (3): 261-270
Vatanparast H, Chilibeck PD. Dose the effect of soy phytoestrogens on bone postmenopausal women depend on the equolproducing phenotype? Nutr Rev 2007; 65(6 pt 1): 294-299
Wu J, Oka J, Ezaki J, Ohtomo T, Ueno T, Uchiyama S, Toda T, Uebra M, Ishimi Y. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controled trial. Menopause 2007; 4(5): 866-874
Ye YB, Tang XY, Verbruggen MA, Su YX. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women: a singleblind randomized placebo-controlled trial. Eur J Nutr 2006; 45 (6): 327-334
Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001; 97 (1): 109-115
Brodowska A. The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes. Ann Acad Med Stetin 2003; 49: 111-133
Karck U, Breckwoldt M. Low-dose oral contraception and bone density. Ther Umsch 2001; 58(9): 547-551
Bailey DAm McKay HA, Mirwald R, Crocker PR, Faulkner RA. A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: The university of Saskatchewan bone mineral accrual study. J Bone Miner Res 1999; 14(10): 1672-1679
Sievanen H, McKay H, Heinonen A, Bailey D, Khan K. The Achilles heel of exercise. Lancet 2000; 355(9202): 469-470
Loh KY, Shonq HK. Osteoporosis: primary prevention in the community. Med J Malaysia 2007; 62(4): 355-357
Park JH, Omi N, Nosaka T, Kitajima A, Ezawa I. Estrogen deficiency and low-calcium diet increased bone loss and urinary calcium excretion but did not altor arterial stiffness in young female rats. J Bone Miner Metab 2008; 26(3): 218-225
Gartner R. Osteoporosis in the elderly-diagnosis and treatment. MMW Fortschr Med 2005; 147(7): 35-36
Bush RA. Female high-school varsity athletics: An opportunity to improve bone mineral density. J Sci Med Sport 2008; [Epub ahead of print]
Bianco V, Filippi F, Tassan-simonat P, Valente I, D'Amico C, Meroni M. Diet assessment and the screening for osteoporosis: a survey in a healthy menopause population. Minerva Ginecol 2008; 60(4): 299-310
Burrows M, Shepherd H, Bird S, Macleod K, Ward B. The components of the female athlete tried donot identify all physically active female at risk. J Sports Sci 2007; 25(12): 1289-1297
Estok PJ, Sedlak CA, Doheny MO, Hall R. Structural model for osteoporosis preventing behavior in postmenopausal women. Nurs Res 2007; 56(3): 148-158
Schwab P, Klein RF, Nonpharmacological approaches to improve bone health and reduce osteoporosis. Curr Opin Rheumatol 2008; 20(2): 213-217
Kamel HK. Postmenopausal osteoporosis: etiology, current diagnostic strategies and nonprescription interventions. J Manaq Care Pharm 2006; 12(6s): s4-9
Carvalho DC, Garlipp CR, Bottini PV, Afaz SH, Moda MA, Cliquet A Jr. Effect of treadmill gait on bone markers and bone mineral density of quadriplegic subjects. Braz J Med Biol Res 2006; 39(10): 1357-1363
Na HB, Kim HJ, Park J. Effect of calcium supplementation and exercise on bone mineral density in middle aged women. Korean J Nutr 2003;, 35(9): 962-969
Sung CJ, Kim SY, Lee JK, Yun ME, Kim MH. Effect of soymilk and bone mineral density and bone metabolism pelated markers in under-weight college women with low bone density. Korean J Community Nutrition 2003; 5(3): 132-140
Sung CJ, Yun ME, Lee JK, Kim MH, Lee HS. Effects of soy isoflavone supplementation and exercise on bone mineral density and urinary deoxypyridinoline in postmenopausal women. Koran J Nutr 2004; 37(4): 291-301
Lieberman S, Bruning N. The real vitamin & mineral book. Avery publishing group. Garden city park, New york; 1997
Levesgue M, Martineau C, Jumarie C, Moreau R. Characterization of cadmium uptake and cytotoxicity in human osteoblast-like MG-63 cells. Toxicol Appl Pharmacol 2008; [Epub ahead of print]
Wong MY, Lane NE. Medication-induced osteoporosis. Curr Osteoporos Rep 2007; 5(4): 139-145
Valente M, Bufalino L, Castiglione GN, D'Angelo R, Mancuso A, Galoppi P, Zichella L. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int 1994; 54(5): 377-380
Bureau I, Anderson RA, Arnauud J, Raysiguier Y, Favier AE, Roussel AM. Trace mineral status in post menopausal women: impact of hormonal replacement therapy. J Trace Elem Biol 2002; 16(1): 9-13
Kotkowiak L. Behavior of selected bio-elements in women with osteoporosis. Ann Acad Med Stetin 1997; 43: 225-238
Rico H, Roca-Botran C, Hernandez ER, SEco C, Paez E, Valencia MJ, Villa LF. The effect of supplemental copper on osteopenia induced by ovariectomy in rats. Menopause 2000; 7(6): 413-416
Klavy LM. Lack of a recommended dietary allowance for copper may be hazardous to your health. J Am Coll Nutri 1998; 17 (4): 322-326
Relea P, Revilla M, Ripoll E, Arribas IF, Rico H. Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 1995; 24(4): 303-307
Herzberg M, Lusky A, Blonder J, Frenkel Y. The effect of estrogen replacement on zinc in serum and urine. Obstet Gynecol 1996; 87(6): 1035-1040
Valente M, Bufalino L, Castiglione GN, D'Angelo R, Mancuso A, Galoppi P, Zichella L. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int 1994; 54(5): 377-380
Itoh R, Nishiyama N, Suyama Y. Dietary protein intake and urinary excretion of calcium: a cross-sectional study in a healthy Japanese population. Am J Clin Nutr 1998; 67(3): 438-444
Munger RG, Cerhan JR, Chiu Chiu BC, Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women. Am J Clin Nutr 1999; 69(1): 147-152
Schlemmer A, Podenphant J, Riis BJ, Christiansen C. Urinary magnesium in early postmenopausal women. influence of hormone therapy on calcium. Magnes Trace Elem 1991; 10(1): 34-39
Lee DH, Sung CJ. Effect of soy isoflavone supplementation on bone metabolism maker and urinary mineral excretion in postmenopausal women. Koran J Nutr 2003; 35(6): 476-482
Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JR JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenoapusal women. Am J Clin Nutr 1998; 68(s): S1375-S1379
Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000; 72(3): 844-852
Recker RR, Saville PD, Heaney RP. Effect of estrogens and calcoum carbonate on bone loss in postmenopausal women. Ann Intern Med 1977; 87: 649-655
Nordin BEC, Morris HA. The calcium deficiency model for osteoporosis. Nut Rev 1989; 47: 65-72
Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL. Rate of bone loss in postmenopausal women randomized to two dosages of vitamine D. Am J Clin Nutr 1995; 61: 1140-1145
Spence LA, Lipscomb ER, Cadogan J, Martin Br, Peacock M, Wastney M, Weaver CM. Effects of soy isoflavones on calcium kinetics in postmenopausal women. J Bone Miner Res 2001; 16: S532
Lipscomb ER, Spence LA, Cadogan J, Martin Br, Peacock M, Weaver CM. Comparative effects of animal and legume proteins on urinary calcium, urinary sulfate, and urynary net acid excretion and kidney function in postmenopausal women. J Bone Miner Res 2001; 16: S532
Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 2003; 88(3): 1048-1054
Cecchettin M, Bellometti S, Cremonesi G, Solimeno LP, Torri G. Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis. Biomed & Pharmacother 1995; 49: 465-468
shizawa N, Fujimura R, Tokuyama K, Suzuki M. A bout of resistance exercise increase urinary calcium independently of osteoclast activation in man. J Appl Physio 1997; 83(4): 1159-1163
Danz AM, Zittermann A, Schiedermaier U, Klein K, Hotzel D, Schonau E. The effect of a specific strength-development exercise on bone mineral density in perimenopausal and postmenopausal women. J Womens Health 1998; 7(6): 701-709
Kaplan B, Neri A, Kitai E, Pardo Y, Blum M, Freidman J. Low dose estrogen replacement therapy in early postmenopausal women effect on urinary magnesium and calcium: creatinine ratios. Clin Exp Obstet Gynecol 1994; 21(3): 170-172
Schlemmer A, Podenphant J, Riis BJ, Christiansen C. Urinary magnesium in early postmenopausal women. influence of hormone therapy on calcium. Magnes Trace Elem 1991; 10(1): 34-39
Mcnair P, Christiansen C, Transbol I. Effect of menopause and estrogen substitutional therapy on magnesiun metabolism. Miner Electrolyte Metab 1984; 10(2): 84-87
Prince LR, Smith M, Dick IM, Price RI, Webb PG, Henderson NK, Harris MM. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. New England Journal of Medicine 1991; 325: 1189
Ohry A, Shemesh Y, Zak R, Herzberg M. Zinc and osteoporosis in patients with spinal cord inhury. Paraplegia 1980; 18(3): 174-180
Szathmari M, Steczek K, Szucs J, Hollo I. Zinc excretion in osteoporotic women. Orv Hetil 1993; 134(17): 911-914
※ AI-Helper는 부적절한 답변을 할 수 있습니다.